SCHEMBL2370111

SCHEMBL2370111

COC(=O)c1ccc(CSc2cccc3c2CC(Cl)N(C(=O)OC(C)(C)C)CC3)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 1/20 0.38
UCHL1 P09936 5/20 0.34
USP30 Q70CQ3 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
GHSR Q92847 4/20 0.34
GPR119 Q8TDV5 2/20 0.34
TSHR P16473 4/20 0.34
MAPK1 P28482 2/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RECQL P46063 1/20 0.33
THRB P10828 1/20 0.32
PRMT5 O14744 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL508000 0.82 UCHL1 (0.35) HDAC1HDAC6UCHL1USP30KMT2A
SCHEMBL10228733 0.75 ESR2 (0.38) HDAC1HDAC6KMT2AGPR119THRB
SCHEMBL508001 0.72 MAPT (0.36) HDAC1HDAC6UCHL1USP30KMT2A
SCHEMBL4550838 0.68 KMT2A (0.58) NPC1RAB9AKMT2ATSHRMAPK1
SCHEMBL507266 0.66 ESR2 (0.39) KMT2AGPR119THRB
SCHEMBL5462270 0.64 GPR119 (0.49) HDAC6NPC1RAB9AGPR119
SCHEMBL30392852 0.64 HDAC1 (0.49) HDAC1HDAC6UCHL1USP30NPC1
SCHEMBL26100769 0.64 HDAC1 (0.49) HDAC1HDAC6UCHL1USP30NPC1
SCHEMBL10274752 0.64 TP53 (0.40) NPC1RAB9AKMT2AMAPK1ALDH1A1
SCHEMBL18422744 0.64 SCN9A (0.40) HDAC1HDAC6GPR119MAPK1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022062-B2 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists ELI LILLY AND COMPANY (US) 2011-09-20 US disclosed
US-20090099155-A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS ARRAY BIOPHARMA, INC. 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099155-A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS HTR2C, HTR5A, HTR4 HDAC1 1188/4885HDAC6 1861/4885UCHL1 4166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.